VELLA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.590
EU - Europa 1.285
AS - Asia 991
SA - Sud America 228
AF - Africa 15
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.115
Nazione #
US - Stati Uniti d'America 2.517
SG - Singapore 465
IE - Irlanda 412
UA - Ucraina 287
BR - Brasile 203
CN - Cina 189
HK - Hong Kong 147
GB - Regno Unito 137
DE - Germania 109
IT - Italia 102
IN - India 61
CA - Canada 55
SE - Svezia 51
FI - Finlandia 48
CH - Svizzera 43
TR - Turchia 28
FR - Francia 19
BE - Belgio 18
ES - Italia 14
JP - Giappone 14
IL - Israele 12
MX - Messico 12
BD - Bangladesh 11
VN - Vietnam 11
IR - Iran 8
NL - Olanda 8
PL - Polonia 8
IQ - Iraq 7
PK - Pakistan 7
RU - Federazione Russa 7
AR - Argentina 6
EC - Ecuador 6
EE - Estonia 6
CO - Colombia 5
AU - Australia 4
ID - Indonesia 4
MA - Marocco 4
PT - Portogallo 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
KR - Corea 3
VE - Venezuela 3
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
LT - Lituania 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DZ - Algeria 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LY - Libia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.115
Città #
Dallas 473
Dublin 412
Chandler 263
Jacksonville 252
Singapore 244
San Jose 185
Hong Kong 145
Ashburn 113
London 112
Boardman 111
The Dalles 101
Chicago 100
Beijing 90
Wilmington 68
Santa Clara 63
Helsinki 48
Dearborn 46
Toronto 43
Zurich 43
San Mateo 29
Capo D'orlando 27
Princeton 27
Istanbul 20
São Paulo 20
Ann Arbor 19
Brussels 18
Columbus 17
Falls Church 16
Leawood 16
Los Angeles 16
Padova 14
Tokyo 12
Council Bluffs 11
Frankfurt am Main 11
Azor 10
Catania 10
Hefei 10
New Orleans 10
New York 10
Augusta 9
Brooklyn 9
Kunming 9
Milan 9
Norwalk 9
Chennai 8
Edinburgh 8
Hillsboro 8
Monmouth Junction 8
Munich 8
Madrid 7
Orem 7
Pune 7
Warsaw 7
Belo Horizonte 6
Düsseldorf 6
Naples 6
Rio de Janeiro 6
Tallinn 6
Atlanta 5
Manchester 5
Mexico City 5
Porto Alegre 5
Rome 5
San Francisco 5
Amsterdam 4
Assago 4
Boston 4
Des Moines 4
Ho Chi Minh City 4
Kyiv 4
Messina 4
Mumbai 4
Nanchang 4
Quito 4
Seattle 4
Tashkent 4
Ardabil 3
Bangalore 3
Campinas 3
Charlotte 3
Goiânia 3
Guangzhou 3
Gunzenhausen 3
Jaipur 3
Jakarta 3
Johannesburg 3
Joinville 3
Lauterbourg 3
Montreal 3
Nanjing 3
Osasco 3
Piscataway 3
Reston 3
Seoul 3
Wuhan 3
Antakya 2
Aracaju 2
Atibaia 2
Basra 2
Brasília 2
Totale 3.523
Nome #
The p53-homologue p63may promote thyroid cancer progression 163
p53 family proteins in thyroid cancer 154
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 150
TAp63α antagonizes p53 oncosuppressor function in thyroid cancer cells 148
p73 Tumor-Suppressor Activity is Impaired in Human thyroid Cancer 145
Metabolic alterations of thyroid cancer as potential therapeutic targets 136
BRAF(V600E) mutation and the biology of papillary thyroid cancer 135
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 120
Anaplastic Thyroid Cancer in Sicily: The Role of Environmental Characteristics 118
Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid 113
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 112
IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway 112
Immunostaining for MET/HCF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 111
Interleukin-4 stimulates papillary thyroid cancer cell survival: implications in patients with thyroid cancer and concomitant Graves' disease 110
P73 tumor-suppressor activity is impaired in human thyroid cancer 106
Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses 102
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer 97
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 97
Levels of histone acetylation in thyroid tumors. 96
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 96
Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? 94
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 91
The IGF system in thyroid cancer:new concepts 87
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 87
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 86
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 85
TAp73 Increases tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 85
Il BRAF(V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al Gefitinib 82
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis 82
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 78
Thyrospheres: a new in vitro model for testing human thyroid endocrine disruptors 77
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome 75
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 75
Influence of Mediterranean Diet on Sexual Function in People with Metabolic Syndrome: A Narrative Review 74
COVID-19 and Diabetes: The Importance of Controlling RAGE 73
Identification of Thyroid Cancer Stem Cells 73
miRNA upregulation in thyroid cancer is caused by the inhibition of the p53 pathway 73
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 72
In IGF-IR deficient leiomyosarcoma cells IGF-II stimulates biological effects via the insulin receptor isoform A 70
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? 68
Genome wide analysis in papillary thyroid carcinoma 67
Insulin Receptor Isoforms in Physiology and Disease: An Updated View 66
Insulin/IGF axis and the Receptor for Advanced Glycation End Products: role in meta-inflammation and potential in cancer therapy 62
Editorial: Early diagnoses and treatments of uncommon breast cancers 60
The expression of PTEN tumor suppressor is down regulated by dominant negative p73 isoform ΔNp73 in thyroid cancer cells 60
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 56
Regulation of miRNAs by p53 family members in thyroid cancer cells 53
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 52
Thyrospheres an in vitro model for human thyroid carcinogenesis 51
Reactivation of p53 mutants by small compounds may represent an adjuvant therapy of poorly differentiated thyroid cancer 50
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axis 50
Role of Braf (v600) mutation in the resistance to Gefitinib of thyroid cancer cells. 49
Isolation of thyroid cancer stem cells 48
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling 35
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress 34
null 33
null 29
null 29
null 27
null 26
null 25
null 25
null 25
null 25
null 24
null 24
null 23
null 22
null 22
null 21
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway. 7
Totale 5.188
Categoria #
all - tutte 31.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.766


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 76 43
2021/2022267 0 0 4 69 9 25 3 59 21 27 15 35
2022/2023854 62 19 29 121 128 108 14 104 122 26 99 22
2023/2024634 40 76 46 27 71 24 86 26 23 24 119 72
2024/2025963 37 56 83 34 122 87 130 48 94 101 117 54
2025/20261.551 88 343 234 151 65 90 189 135 116 109 31 0
Totale 5.188